These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24716006)

  • 1. Rhabdomyolysis induced by nonstrenuous exercise in a patient with graves' disease.
    Summachiwakij S; Sachmechi I
    Case Rep Endocrinol; 2014; 2014():286450. PubMed ID: 24716006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyolysis associated with hyperthyroidism.
    Lichtstein DM; Arteaga RB
    Am J Med Sci; 2006 Aug; 332(2):103-105. PubMed ID: 16909061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotoxic Periodic Paralysis and Cardiomyopathy in a Patient with Graves' Disease.
    Abbasi AA; Chandar P; Shankar S; Gupta SS; Kupfer Y
    Cureus; 2018 Jun; 10(6):e2837. PubMed ID: 30131930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature.
    Erem C
    Endocrine; 2005 Jun; 27(1):63-5. PubMed ID: 16077173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition.
    Tella SH; Kommalapati A
    Cureus; 2015 Oct; 7(10):e342. PubMed ID: 26623197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
    Lohiya S; Lohiya V; Stahl EJ
    Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease coexisted with resistance to thyroid hormone: a case report.
    Akahori H; Usuda R
    J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pop-provoked paralysis: silent Graves' disease presenting as thyrotoxic periodic paralysis.
    Sehmer B; Arnason T
    BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23203166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.
    Neto AM; Tambascia MA; Brunetto S; Ramos CD; Zantut-Wittmann DE
    Cases J; 2009 Aug; 2():8479. PubMed ID: 19918435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient.
    Matta A; Koppala J; Gossman W
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24717588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotoxic periodic paralysis as an initial presentation of Graves' disease in a Saudi patient.
    Alqahtani SF; Aleithan MM
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28630226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Alcohol Abuse-Induced Hypokalemia Might Lead to Delayed Diagnosis or Misdiagnosis of Thyrotoxic Periodic Paralysis.
    Lin YY; Hsieh YS
    Cureus; 2021 Jun; 13(6):e15880. PubMed ID: 34336407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxic periodic paralysis: a case report and literature review.
    Barahona MJ; Vinagre I; Sojo L; Cubero JM; Pérez A
    Clin Med Res; 2009 Sep; 7(3):96-8. PubMed ID: 19625499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.